Cytokinetics Inc (CYTK): Next-Year EPS Estimate 28.10%
As of 2026-06-04, Cytokinetics Inc (CYTK) has a next-year EPS growth estimate of 28.10%.
On 2026-05-19, analyst consensus for CYTK's next-year EPS growth shifted from 28.01% to 28.10% — a positive change of 0.09 percentage points. The revised estimate has been sustained across 13 subsequent trading sessions. Current-year growth is projected at 2.38%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 28.10%
- EPS growth this year
- 2.38%
- EPS next quarter (est)
- -$1.63
- Last price
- $72.29
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 28.10% | 2.38% | -$1.63 | $72.29 |
| 2026-06-03 | 28.10% | 2.38% | -$1.63 | $70.71 |
| 2026-06-02 | 28.10% | 2.38% | -$1.63 | $70.91 |
| 2026-06-01 | 28.10% | 2.38% | -$1.63 | $73.68 |
| 2026-05-31 | 28.10% | 2.38% | -$1.63 | $76.76 |
| 2026-05-28 | 28.10% | 2.38% | -$1.63 | $76.81 |
| 2026-05-27 | 28.10% | 2.38% | -$1.63 | $77.15 |
| 2026-05-26 | 28.10% | 2.38% | -$1.63 | $76.29 |
| 2026-05-25 | 28.10% | 2.38% | -$1.63 | $76.94 |
| 2026-05-24 | 28.10% | 2.38% | -$1.63 | $76.94 |
| 2026-05-21 | 28.10% | 2.38% | -$1.63 | $78.06 |
| 2026-05-20 | 28.10% | 2.38% | -$1.63 | $78.77 |
| 2026-05-19 | 28.10% | 2.38% | -$1.63 | $76.45 |
| 2026-05-18 | 28.01% | 1.16% | -$1.65 | $75.18 |
| 2026-05-17 | 28.01% | 1.16% | -$1.65 | $75.85 |
| 2026-05-14 | 27.97% | 1.21% | -$1.65 | $78.64 |
| 2026-05-13 | 27.98% | 1.21% | -$1.65 | $76.91 |
| 2026-05-12 | 27.98% | 1.21% | -$1.65 | $74.81 |
| 2026-05-11 | 27.93% | 0.80% | -$1.66 | $74.56 |
| 2026-05-10 | 28.49% | 1.36% | -$1.66 | $76.91 |
| 2026-05-07 | 27.88% | 2.06% | -$1.65 | $74.29 |
| 2026-05-06 | 27.47% | 1.58% | -$1.65 | $74.84 |
| 2026-05-05 | 26.91% | 1.28% | -$1.65 | $77.09 |
| 2026-05-04 | 27.18% | 0.52% | -$1.65 | $66.05 |
| 2026-05-03 | 27.18% | 0.52% | -$1.65 | $63.35 |
| 2026-04-30 | 27.17% | 0.52% | -$1.65 | $63.97 |
| 2026-04-29 | 27.21% | 0.55% | -$1.65 | $59.58 |
| 2026-04-28 | 27.21% | 0.55% | -$1.65 | $60.69 |
| 2026-04-27 | 27.21% | 0.55% | -$1.65 | $61.60 |
| 2026-04-26 | 27.21% | 0.55% | -$1.65 | $65.32 |
Recent News
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)GlobeNewswire
- Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare ConferenceGlobeNewswire
- Cytokinetics Announces New Data Related to MYQORZO (aficamten) at ESC Heart Failure 2026GlobeNewswire
- Cytokinetics Announces Pricing of Upsized Public Offering of Common StockGlobeNewswire
- Cytokinetics: Q1 Earnings SnapshotAssociated Press
- Cytokinetics stock hits 52-week high after ACACIA-HCM trialQuartz
- Cytokinetics stock hits 52-week high after heart drug passes expanded Phase 3 trialQuartz
- This Small Biotech Just Snapped Up A Win Where Chief Rival Bristol Myers FailedInvestor's Business Daily
- Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic CardiomyopathyGlobeNewswire
- Cytokinetics heart drug scores in closely watched trialBioPharma Dive
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Cytokinetics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Cytokinetics Inc (CYTK) has a next-year EPS growth estimate of 28.10%, based on analyst consensus.
When was the latest EPS estimate revision for CYTK?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 28.01% to 28.10%.
What sector and industry does Cytokinetics Inc belong to?▾
Cytokinetics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CYTK appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Cytokinetics Inc (CYTK) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports